Clearwater Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.42M | Buy |
263,717
+67,842
| +35% | +$1.65M | 0.59% | 35 |
|
|
2025
Q1 | $4.07M | Buy |
195,875
+37,970
| +24% | +$788K | 0.39% | 41 |
|
|
2024
Q4 | $3.72M | Sell |
157,905
-26,019
| -14% | -$613K | 0.36% | 41 |
|
|
2024
Q3 | $4.71M | Buy |
183,924
+11,263
| +7% | +$288K | 0.46% | 39 |
|
|
2024
Q2 | $4.05M | Sell |
172,661
-1,098
| -0.6% | -$25.8K | 0.43% | 38 |
|
|
2024
Q1 | $5M | Buy |
173,759
+6,385
| +4% | +$184K | 0.53% | 38 |
|
|
2023
Q4 | $5.49M | Sell |
167,374
-75,662
| -31% | -$2.48M | 0.62% | 33 |
|
|
2023
Q3 | $6.77M | Buy |
243,036
+280
| +0.1% | +$7.8K | 0.83% | 28 |
|
|
2023
Q2 | $8.28M | Sell |
242,756
-39
| -0% | -$1.33K | 0.99% | 27 |
|
|
2023
Q1 | $7.3M | Sell |
242,795
-3,117
| -1% | -$93.7K | 0.89% | 28 |
|
|
2022
Q4 | $6.94M | Buy |
245,912
+41,053
| +20% | +$1.16M | 0.9% | 31 |
|
|
2022
Q3 | $6.73M | Buy |
204,859
+37,245
| +22% | +$1.22M | 0.93% | 33 |
|
|
2022
Q2 | $5.28M | Sell |
167,614
-37,012
| -18% | -$1.17M | 0.72% | 36 |
|
|
2022
Q1 | $9.4M | Buy |
204,626
+57,985
| +40% | +$2.66M | 1.08% | 27 |
|
|
2021
Q4 | $8.98M | Sell |
146,641
-651
| -0.4% | -$39.9K | 0.99% | 31 |
|
|
2021
Q3 | $11M | Buy |
147,292
+8,403
| +6% | +$628K | 1.28% | 24 |
|
|
2021
Q2 | $12.8M | Buy |
138,889
+6,121
| +5% | +$566K | 1.49% | 20 |
|
|
2021
Q1 | $11.8M | Buy |
132,768
+13,066
| +11% | +$1.16M | 1.47% | 18 |
|
|
2020
Q4 | $11.2M | Buy |
119,702
+15,464
| +15% | +$1.44M | 1.48% | 21 |
|
|
2020
Q3 | $6.64M | Buy |
104,238
+9,277
| +10% | +$591K | 1.04% | 24 |
|
|
2020
Q2 | $4.95M | Buy |
+94,961
| New | +$4.95M | 0.83% | 29 |
|